Prognostic value of a decrease in mean platelet volume, platelet distribution width, and platelet-large cell ratio...

Area of Science:

• Cardiology
• Hematology
• Clinical Medicine

Background:

• Platelet indices like PDW, P-LCR, and MPV are increasingly recognized for their role in cardiovascular disease.
• Assessing prognostic markers in acute myocardial infarction without ST-segment elevation (NSTEMI) is crucial for patient management.

Purpose of the Study:

• To investigate the prognostic value of changes in platelet distribution width (PDW), platelet-large cell ratio (P-LCR), and mean platelet volume (MPV) for major adverse cardiovascular events (MACEs) in NSTEMI patients treated with clopidogrel.
• To determine if a specific threshold of PDW decrease can predict short-term MACE risk.

Main Methods:

• Prospective observational cohort study of 170 NSTEMI patients.
• Measurement of PDW, P-LCR, and MPV on hospital admission and 24 hours post-clopidogrel treatment.
• One-year follow-up for MACE assessment, utilizing Cox regression and Kaplan-Meier analyses.

Main Results:

• A significant association was found between a decrease in PDW and reduced incidence of MACEs and improved overall survival.
• Patients with a PDW decrease <9.9% 24 hours post-treatment exhibited significantly higher MACE rates and lower survival.
• No significant prognostic value was observed for decreases in MPV or P-LCR.

Conclusions:

• A decrease in PDW <9.9% 24 hours after clopidogrel initiation serves as a valuable prognostic marker for short-term MACE risk in NSTEMI patients.
• This finding may aid in the risk stratification of NSTEMI patients treated with clopidogrel.
• Platelet distribution width holds prognostic significance in NSTEMI management.